Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Raddi
Observed names:
M. Raddi,
Raddi Marco,
Raddi, Marco
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
University of Campania "Luigi Vanvitelli",
Azienda Ospedaliero-Universitaria Careggi,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Florence,
University of Naples Federico II
ORCID:
0000-0002-6820-8831
Observed ORCID:
0000-0002-6820-8831
OpenAlex ID:
A5003785144
Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
2022
·
Costantina Maisto
, Michela Aurilio
, et al.
·
Molecules
·
29
PDF
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
2017
·
Barbara Salvatore
, Michele Klain
, et al.
·
Medicine
·
25
A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice
2023
·
Valentina Pirozzi Palmese
, Laura D’Ambrosio
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
18
PDF
On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact
2021
·
Costantina Maisto
, Anna Morisco
, et al.
·
EJNMMI Radiopharmacy and Chemistry
·
17
PDF
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting
2025
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
8
PDF
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study
2023
·
C. Cardone
, A. De Stefano
, et al.
·
ESMO Open
·
8
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings
2026
·
Matteo Bauckneht
, Laura Evangelista
, et al.
·
Clinical and Translational Imaging
·
3
PDF
Stefano Fanti and Egesta Lopci (Editors): Diagnostic nuclear medicine and radionuclide therapy
2017
·
Marco Raddi
, Luigi Mansi
·
European Journal of Nuclear Medicine and Molecular Imaging
·
1
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial
2026
·
Rossella Di Franco
, Simona Mercogliano
, et al.
·
Figshare
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial
2026
·
Rossella Di Franco
, Simona Mercogliano
, et al.
·
Future Oncology
PDF
Dosimetric comparison between 177LU-PSMA-617 and 177LU-PSMA I&T in patients with metastatic castration resistant prostate cancer (MCRPC) using a ring-shaped CZT-based camera
2026
·
L. D’Ambrosio
, F. Manna
, et al.
·
Physica Medica
Treatment - Current Treatment Options - Higher Risk Mds
2025
·
Valeria Santini
, Sven Depourcq
, et al.
·
Leukemia Research
Dosimetry in Patients Treated With Lutetium-177 Labelled Peptides: the Int G. Pascale Experience
2023
·
V. Pirozzi Palmese
, L. D’Ambrosio
, et al.
·
Physica Medica
Comparison of [68Ga]Ga-PSMA-11, [18F]PSMA1007 and [177Lu]Lu-PSMA-617 in detecting the same prostate cancer lesions. The evidences from the clinical practice in a dedicated Cancer Institution.
2023
·
de Marino, Roberta
, Morisco, Anna
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase 2 study
2022
·
Cardone, Claudia
, De Stefano, Alfonso
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
P-68 Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): An academic, multicenter, single-arm, two-stage, phase 2 study
2022
·
C. Cardone
, M. Piccirillo
, et al.
·
Annals of Oncology
Analysis of Pros and Cons in using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: production, costs and PET/CT applications in patients with Prostate Cancer.
2022
·
Maisto Costantina
, Aurilio Michela
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
17
Citation count:
109
H-index:
6
I10-index:
4
Year
Topic
Type